MedPath

Naloxone Hydrochloride

Naloxone Hydrochloride Injection, USP

Approved
Approval ID

7faaedb3-227b-408d-b772-6b326638b00e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 22, 2021

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naloxone Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-992
Application NumberANDA213843
Product Classification
M
Marketing Category
C73584
G
Generic Name
Naloxone Hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateOctober 22, 2021
FDA Product Classification

INGREDIENTS (2)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
NALOXONE HYDROCHLORIDEActive
Quantity: 1 mg in 1 mL
Code: F850569PQR
Classification: ACTIM

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 10/22/2021

Rx only Opioid Antagonist

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naloxone Hydrochloride - FDA Drug Approval Details